Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.
Pleno has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in December 2024.
Pleno's investors include Deerfield Management, Deerfield, Foresite Capital, Alexandria Venture Investments, Medical Excellence Capital.
Pleno is headquartered in San Diego, United States.
Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.
Pleno is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pleno — Funding & Investors." VCBacked, December 12, 2024, https://www.vcbacked.co/company/pleno. Accessed September 15, 2026.
VCBacked. (2024). Pleno — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/pleno
{{cite web |title=Pleno — Funding & Investors |url=https://www.vcbacked.co/company/pleno |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated